Last $6.76 USD
Change Today -0.04 / -0.59%
Volume 449.4K
DYAX On Other Exchanges
Symbol
Exchange
Frankfurt
As of 12:07 PM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Gregory D. Phelps

Former Director, Dyax Corp.
AgeTotal Calculated CompensationThis person is connected to 21 board members in 2 different organizations across 4 different industries.

See Board Relationships
64--

Background*

Mr. Gregory D. Phelps, Greg, served as the Chairman, President and Chief Executive Officer of RenaMed Biologics Inc. from October 2004 to April 2007. Mr. Phelps served as the Chairman and Chief Executive Officer of Nephros Therapeutics Inc., a biotechnology company developing therapeutic products. His career has been focused for over thirty years in the medical products and biotechnology fields, where he has held Chief Executive Officer and other executive management ...

Read Full Background

Corporate Headquarters*

55 Network Drive
Burlington, Massachusetts 01803

United States

Phone: 617-225-2500
Fax: 617-225-2501

Board Members Memberships*

1998-N/A
Former Director
2004-Present
Independent Director, Chairman of Nominating & Governance Committee and Member of Audit Committee
2004-2008
Former Chairman, Chief Executive Officer and President
2008-Present
Chairman

Education*

MBA
Harvard Business School
BS
Bradley University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DYAX:US $6.76 USD -0.04

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Jon P. Stonehouse Chief Executive Officer, President and Executive Director
BioCryst Pharmaceuticals, Inc.
$475.7K
Sijmen de Vries M.D., MBAChief Executive Officer and Member of Management Board
Pharming Group NV
€594.0K
John W. Varian Chief Executive Officer, President and Director
XOMA Corporation
$489.3K
Michael S. O. Oredsson B.Int’l Bus Admin (Lund)Chief Executive Officer and President
BioInvent International AB
kr735.0K
Jan G. J. van de Winkel Ph.D.Co-Founder, Chief Executive Officer and President
Genmab A/S
kr10.7M
Compensation as of Fiscal Year 2013.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYAX CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.